Meeting
2023 ASCO Genitourinary Cancers Symposium
18F-DCFPyL PET in first BCR and initial staging: Concordance with conventional imaging.
Authors
Miles Hsu
Abramson Cancer Center, Philadelphia, PA
Miles Hsu , Xinhe Shan , Austin Pantel , Samuel U Takvorian , Jeffrey Shevach , Vivek Narayan , Neha Vapiwala , David J. Vaughn , Naomi B. Haas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 58)
DOI
10.1200/JCO.2023.41.6_suppl.58
Abstract #
58
Poster Bd #
C17
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
PSMA PET imaging for evaluation of recurrent or persistent prostate cancer after primary prostate radiation.
First Author: Richard Bennett IV
Poster
2024 ASCO Genitourinary Cancers Symposium
SABRE: Assessment of safety and efficacy of 64Cu-SAR-BBN in patients with PSMA-negative biochemical recurrent prostate cancer.
First Author: Luke T. Nordquist
Poster
2023 ASCO Annual Meeting
PSMA PET guided salvage radiotherapy among patients with prostate cancer in the post-prostatectomy setting: A single center post-hoc analysis.
First Author: Clayton P Smith
Poster
2023 ASCO Genitourinary Cancers Symposium
The impact of F-18 PSMA PET imaging on clinical decision-making in prostate cancer across disease states.
First Author: Ali Arafa